GlassScriptPhysician profile
Evan O Mokwe
NPI 1346389335
$7,475.05
in general payments reported to CMS, 2019-2025
26 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,174 · 2020: $612 · 2021: $961 · 2022: $1,059 · 2023: $1,039 · 2024: $248 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,669.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,958.70 | 2019-2025 | Pressurewire, Jot Dx, Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $746.96 | 2019-2025 | Lifevest |
| Penumbra, INC. | $530.30 | 2022 | |
| Alnylam Pharmaceuticals INC. | $516.43 | 2019-2025 | Onpattro, Amvuttra |
| Actelion Pharmaceuticals US, INC. | $382.31 | 2019-2021 | |
| Pfizer INC. | $314.39 | 2019-2025 | |
| Abiomed | $262.08 | 2021 | |
| Novartis Pharmaceuticals Corporation | $259.57 | 2019-2025 | |
| Cvrx, INC. | $221.76 | 2023-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $205.85 | 2020-2025 | Camzyos, Eliquis |
| Angiodynamics, INC. | $201.86 | 2022 | |
| Biotronik INC. | $146.86 | 2019 | |
| Medtronic Vascular, INC. | $125.41 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $115.45 | 2019-2023 | Xarelto |
| Cardiovascular Systems INC. | $74.42 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $66.33 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $60.14 | 2023 | Brilinta, Farxiga |
| Cardiva Medical, INC. | $50.94 | 2022 | |
| Elutia, INC. | $50.36 | 2021 | |
| Irhythm Technologies, INC. | $44.81 | 2023 | Zio Xt Patch |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.17 | 2021 | |
| Medtronic, INC. | $29.80 | 2023 | Corevalve Evolut R |
| Lexicon Pharmaceuticals, INC. | $23.68 | 2024 | |
| Arbor Pharmaceuticals, INC. | $17.00 | 2019 | |
| Lilly USA, LLC | $14.68 | 2021 | |
| Tactile Systems Technology INC | $13.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Mokwe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.